Adcetris May Cost $4,500 Per Vial, Or Over $100,000 For A Course Of Lymphoma Treatment. Adcetris (brentuximab vedotin), as of late FDA affirmed for Hodgkin lymphoma and foundational anaplastic enormous cell lymphoma, may cost over $100,000 for a course of treatment, or $4,500 per vial.